Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2.

ABSTRACT: Despite the importance of nucleic acid testing in managing the COVID-19 pandemic, current detection approaches remain limited due to their high complexity and extensive processing. Here, we describe a molecular nanotechnology that enables direct and sensitive detection of viral RNA targets in native clinical samples. The technology, termed catalytic amplification by transition-state molecular switch (CATCH), leverages DNA-enzyme hybrid complexes to form a molecular switch. By ratiometric tuning of its constituents, the multicomponent molecular switch is prepared in a hyperresponsive state-the transition state-that can be readily activated upon the binding of sparse RNA targets to turn on substantial enzymatic activity. CATCH thus achieves superior performance (~8 RNA copies/μl), direct flu

SUBMITTER: Sundah NR 

PROVIDER: S-EPMC7968834 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature